Implications of Transfusion in Adults with Congenital Heart Disease Undergoing Cardiac Surgery

The Year in Review: Anesthesia for Congenital Heart Disease 2023

“…The risks of transfusions have also been reported in the adult congenital heart disease (ACHD) population. A study by Dutta et al 4 investigated the association between perioperative blood product administration and outcomes in ACHD patients undergoing surgery with CPB. This retrospective review included 323 adults >18 years who underwent surgery between 2015 and 2020.…”

A Year of Changes: The End of the Pandemic Marks the Beginning of New Priorities

“…The previous year also revealed exciting publications relevant to anesthesia provided to children and adults with congenital heart disease (CHD), summarized in our current edition by Wadle et al 28 Like last year’s literature on adult cardiac surgery, retrospective studies focused on the association between perioperative transfusions and worse clinical outcomes in pediatric and adult CHD surgery. 29,30 The first documented Norwood procedure performed without the transfusion of blood products, as reported by Bohuta et al, marked a significant milestone in blood conversation techniques. 31 Another main theme was the mitigation of post-cardiopulmonary bypass (CPB) bleeding by different techniques, such as FFP-based prime solutions, more advanced viscoelastic tests, and 4-factor prothrombin complex concentrate.…”